Pacira BioSciences, Inc. (PCRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
5401 West Kennedy Boulevard
Tampa, FL 33609
United States of America (the)
Phone
813 553 6680
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
788
First IPO Date
February 03, 2011
| Name | Title | Pay | Year Born |
| Frank D. Lee | Chief Executive Officer & Director | 2.42M | 1968 |
| Anthony Molloy | Chief Legal & Compliance Officer | 581,410 | 1974 |
| Shawn Cross | Chief Financial Officer | 1.03M | 1968 |
| Kristen Williams | Chief Administrative Officer & Secretary | 1.1M | 1974 |
| Jonathan Slonin | Chief Medical Officer | 1.11M | 1975 |
| Brendan Teehan | Chief Commercial Officer | 1.16M | 1969 |
| Lauren Bullaro Riker | Principal Accounting Officer & Senior Vice President of Finance | 1.95M | 1979 |
| Christopher C. Young | Chief Manufacturing Officer | 0 | 1972 |
| Krys Corbett | Chief Business Officer | 0 | N/A |
| Susan Mesco | Head of Investor Relations | 0 | N/A |
Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inherent molecular structure. Established in 2006, the firm was formerly known as Pacira Pharmaceuticals, Inc. until its name change to Pacira BioSciences, Inc. in April 2019. Its main corporate office is situated in Tampa, Florida.